Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2005.053595v1, 2005; 10.1373/clinchem.2005.053595
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.053595v1
51/10/1830    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Snyder, J. A.
Right arrow Articles by Grenache, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snyder, J. A.
Right arrow Articles by Grenache, D. G.

Received on April 28, 2005
Accepted on July 7, 2005

Endocrinology and Metabolism

Diagnostic Considerations in the Measurement of Human Chorionic Gonadotropin in Aging Women

Jennifer A. Snyder 1, Shannon Haymond 2, Curtis A. Parvin 2, Ann M. Gronowski 2, David G. Grenache 1*

1 Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, School of Medicine, Chapel Hill, NC
2 Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, MO

* To whom correspondence should be addressed. E-mail: dgrenach{at}unch.unc.edu.

Background: Human chorionic gondadotropin (hCG) screening tests are frequently performed on female patients of childbearing age before any medical intervention that could potentially harm a fetus. Although older women usually have negative hCG test results, positive results do occur and may cause clinical confusion. We examined changes with age in serum hCG concentrations in nonpregnant women and investigated the use of serum follicle-stimulating hormone (FSH) measurements as an aid to interpreting higher than expected ("positive") hCG results.

Methods: We used 240 serum specimens for each of 4 female cohorts: pregnant, ≥18 years; nonpregnant, 18-40 years (premenopausal); nonpregnant, 41-55 years (perimenopausal); and nonpregnant, >55 years (postmenopausal). Patients were excluded if they had an ectopic pregnancy, a history of trophoblastic disease, or a germ-cell tumor, or if no chart was available for review. Quantitative hCG and FSH tests were performed on each specimen.

Results: Serum hCG concentrations in nonpregnant women increased with the age of the women. hCG concentration results were higher and significantly different (P <0.0001) for nonpregnant women >55 years (<2.0 to 13.1 IU/L) compared with nonpregnant women 18-40 years (<2.0 to 4.6 IU/L) and 41-55 years (<2.0 to 7.7 IU/L). Nineteen nonpregnant women >40 years of age had hCG concentrations ≥5.0 IU/L, all with an FSH concentration >32.4 IU/L. The highest FSH concentration in pregnancy was 7.3 IU/L.

Conclusions: Serum hCG increases with age in nonpregnant women. A cutoff of 14.0 IU/L should be used when interpreting hCG results in women >55 years of age. Pregnancy is unlikely in perimenopausal women 41-55 years of age with an hCG between 5.0 and 14.0 IU/L if serum FSH is >20.0 IU/L.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
A. M. Gronowski, C. R. Fantz, C. A. Parvin, L. J. Sokoll, C. L. Wiley, M. H. Wener, and D. G. Grenache
Use of Serum FSH to Identify Perimenopausal Women with Pituitary hCG
Clin. Chem., April 1, 2008; 54(4): 652 - 656.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
U.-H. Stenman
Commentary
Clin. Chem., January 1, 2008; 54(1): 213 - 214.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
C. R. McCudden, M. S. Willis, and D. G. Grenache
Persistent Low Concentration of Human Chorionic Gonadotropin in a Nonpregnant Woman
Clin. Chem., January 1, 2008; 54(1): 209 - 213.
[Full Text] [PDF]


Home page
NEJMHome page
L. A. Cole, Y. Sasaki, and C. Y. Muller
Normal Production of Human Chorionic Gonadotropin in Menopause
N. Engl. J. Med., March 15, 2007; 356(11): 1184 - 1186.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
U.-H. Stenman, A. Tiitinen, H. Alfthan, and L. Valmu
The classification, functions and clinical use of different isoforms of HCG
Hum. Reprod. Update, November 1, 2006; 12(6): 769 - 784.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. A. Cole
"Background" Human Chorionic Gonadotropin in Healthy, Nonpregnant Women
Clin. Chem., October 1, 2005; 51(10): 1765 - 1766.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2005 by the American Association for Clinical Chemistry.